Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SV2S
|
|||
| Drug Name |
Tetra-hydro-quinoline derivative 3
|
|||
| Synonyms |
PMID26924192-Compound-84
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
FORMA THERAPEUTICS INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H24FN3O3
|
|||
| Canonical SMILES |
CC1CCC2=C(N1C(=O)OC)C=CC(=C2OCCF)C3=CN(N=C3)C4CC4
|
|||
| InChI |
1S/C20H24FN3O3/c1-13-3-6-17-18(24(13)20(25)26-2)8-7-16(19(17)27-10-9-21)14-11-22-23(12-14)15-4-5-15/h7-8,11-13,15H,3-6,9-10H2,1-2H3/t13-/m0/s1
|
|||
| InChIKey |
LVOBMWBVNYYGFM-ZDUSSCGKSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
| KEGG Pathway | SNARE interactions in vesicular transport | |||
| Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.